Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: Case report and review

Clinical Infectious Diseases

Volumn 18, Issue 2, 1994, Pages 188-193

  John, Chandy C ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CLINICAL FEATURE; DRUG MIXTURE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

CASE REPORT; CEFOTAXIME; CEFTRIAXONE; DRUG RESISTANCE, MICROBIAL; HUMAN; INFANT; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; RIFAMPIN; STREPTOCOCCUS PNEUMONIAE; VANCOMYCIN;

EID: 0028118473     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/18.2.188     Document Type: Article

References (62)

1. Sacho H, Klugman KP, Koornhof HJ. Community-acquired pneumonia in an adult due to a multiply-resistant pneumococcus [letter], J Infect 1987;14:188-9.
2. Klugman KP, KoornhofHJ. Worldwide increase in pneumococcal antibiotic resistance [letter]. Lancet 1989;2:444.
3. Appelbaum PC. World-wide development of antibiotic resistance in pneumococci. Eur J Clin Microbiol 1987;6:367-77.
4. George RC, Cooper PG., Erdman YJ. Not the first multiresistant pneumococcus in Britain [letter], Br Med J 1987;295:1208.
5. Levy J. Antibiotic resistance in Europe and the current use of antibiotics in severe pediatric infections. Scand J Infect Dis Suppl 1990;73:23-9.
6. Schwartz RH, Khan WN, Akram S. Penicillin and trimethoprim-sulfamethoxazole-resistant pneumococci isolated from blood cultures of three infants in metropolitan Washington, D.C.: a harbinger of serious future problems? Pediatr Infect Dis J 1991;10:782-3.
7. Beucler A, Bendersky N., Deborne B, et al. L’infection pneumococcique dans un hopital general de la region Parisienne. Enquete Villeheue-Saint-Georges. Pathol Biol (Paris) 1979;27:525-9.
8. Fenoll A, Bourgon CM, Muñoz R, Vicioso D, Casal J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-89. Rev Infect Dis 1991;13:56-60.
9. Marion A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungaiy. J Infect Dis 1991;163:542-8.
10. Saah AJ, Mallonee JP, Tarpay M, Thornsberry CT, Roberts MA, Rhoades ER. Relative resistance to penicillin in the pneumococcus: a prevalence and case-control study. JAMA 1980;243:1824-7.
11. Program Notes: Arctic Investigations Laboratory, Centers for Disease Control. Intermediate antibiotic resistance of invasive Streptococcus pneumoniae isolates recovered from Alaskan residents. Alaska Med 1990;32:44-5.
12. Eykyn SJ. Pneumococcaemia caused by erythromycin-resistant Streptococcus pneumoniae type 14 [letter]. Lancet 1988;2:1086.
13. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae. Moraxella catarrhalis. and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
14. Ridgway EJ, Allen KD, Neal TJ, Lombard M, Ribgy A. Penicillin-resistant pneumococcal meningitis [letter]. Lancet 1992:339:931.
15. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978;299:735-40.
16. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977;2:995-7.
17. Millar M, Grover M, Osbourne F, Antoniou A. Control of antibiotic-resistant Streptococcus pneumoniae in Romania [letter]. Lancet 1991:338:323.
18. Henderson FW, Gilligan PH, Wait K, Goff DA. Nasopharyngeal carriage of antibiotic-resistant pneumococci by children in group day care. J Infect Dis 1988;157:256-63.
19. Moore EP, Williams EW. Hospital transmission of multiply antibiotic-resistant Streptococcus pneumoniae [letter], J Infect 1988; 16:199-200.
20. Rauch AM, O’Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Tex, daycare center. Am J Dis Child 1990;144:923-7.
21. Lapointe J-R, Joncas JH. Meningitis in a Canadian infant due to pneumococcus resistant to penicillin and chloramphenicol. J Pediatr 1983;103:580-2.
22. Buu-Hoi AY, Goldstein FW, Acar JF. A seventeen-year epidemiological survey of antimicrobial resistance in pneumococci in two hospitals. J Antimicrob Chemother 1988;22(suppl B):41-52.
23. Linares J, Garau J, Domínguez C, Pérez JL. Antibiotic resistance and serotypes of Streptococcus pneumoniae from patients with community-acquired pneumococcal disease. Antimicrob Agents Chemother 1983;23:545-7.
24. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J 1991;10:871-3.
25. Ward J. Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. Rev Infect Dis 1981;3:254-66.
26. Powell M, McVey D, Kassim MH, Chen HY, Williams JD. Antimicrobial susceptibility of Streptococcus pneumoniae. Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J Antimicrob Chemother 1991;28:249-59.
27. Committee on Infectious Diseases. Treatment of bacterial meningitis. Pediatrics 1988;81:904-7.
28. Alonso J, Madrigal V, García-Fuentes M. Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin [letter]. Pediatr Infect Dis J 1991; 10:256.
29. Asensi F, Pérez-Tamarit D, Otero MC, et al. Imipenem-cilastatin therapy in a child with meningitis caused by a multiply resistant pneumococcus [letter], Pediatr Infect Dis J 1989;8:895.
30. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992; 11:662-6.
31. Friedland IR, Shelton S, Paris M. et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1993;12:196-200.
32. Pallares R., Gudiol F, Liñares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987:317:18-22.
33. Jacoby GA, Archer GL. New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991;324:601-12.
34. Baquero F, Martínez-Beltrán J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28(suppl C):31-8.
35. Hakenbeck R, Briese T, Chalkley L, et al. Antigenic variation of penicillin-binding proteins from penicillin-resistant clinical strains of Streptococcus pneumoniae. J Infect Dis 1991;164:313-9.
36. Jorgensen JH, Doern GV, Ferraro MJ, KnappCC. Swenson JM, Washington JA. Multicenter evaluation of the use of Haemophilus test medium for broth microdilution antimicrobial susceptibility testing of Streptococcus pneumoniae and development of quality control limits. J Clin Microbiol 1992;30:961-6.
37. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. M7-A2. 2nd ed. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1990.
38. McCracken GH Jr. Management of bacterial meningitis in infants and children. Current status and future prospects. Am J Med 1984;76 (suppl 5A):215-23.
39. Sande MA. Antibiotic therapy of bacterial meningitis: lessons we’ve learned [editorial]. Am J Med 1981;71:507-10.
40. McCracken GH Jr, Sakata Y. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrob Agents Chemother 1985; 27:141-5.
41. Cherubin CF., Eng RHK, Norrby R, Modai J, Humbert G, Overturf G. Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis 1989;11:526-48.
42. Tenover FC, Swenson JM, McDougal LK. Screening for extended-spectrum cephalosporin resistance in pneumococci [letter]. Lancet 1992:340:1420.
43. Friedland IR, Istre GR. Management of penicillin-resistant pneumococcal infections. Pediatr Infect Dis J 1992:11:433-5.
44. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990;3:171-96.
45. Friedland IR, Klugman KP. Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 1992;146:920-3.
46. Bosley GS, Elliot JA, Oxtoby MJ, Facklam RR. Susceptibility of relatively penicillin-resistant Streptococcuspneumoniaeto newer cephalosporin antibiotics. Diagn Microbiol Infect Dis 1987;7:21-7.
47. Tweardy DJ, Jacobs MR, Speck WT. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. J Antimicrob Chemother 1983; 12:133-9.
48. McCracken GH Jr. Nelson JD, Kaplan SL, Overturf GD, Rodriguez WJ, Steele RW. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J 1987:6:501-5.
49. Weingarten RD, Markiewicz Z, Gilbert DN. Meningitis due to penicillin-resistant Streptococcus pneumoniae in adults. Rev Infect Dis 1990;12:118-24.
50. Ward JI. Moellering RC Jr. Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin. Antimicrob Agents Chemother 1981;20:204-7.
51. Friedland IR, Klugman KP. Recurrent penicillin-resistant pneumococcal meningitis after chloramphenicol therapy. Pediatr Infect Dis J 1991;10:705-7.
52. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992;339:405-8.
53. George RE, Wariyar UK., Rao GG. Penicillin-resistant pneumococcal meningitis [letter]. Lancet 1992;339:931-2.
54. Sakata Y, McCracken GH Jr, Thomas ML, Olsen KD. Pharmacokinetics and therapeutic efficacy of imipenem. ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b. Antimicrob Agents Chemother 1984:25:29-32.
55. Wong VK. Wright HT Jr, Ross LA, Mason WH, Inderlied CB, Kim KS. Imipenem-cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J 1991;10:122-5.
56. Jackson MA. Shelton S, Nelson JD, McCracken GH Jr. Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis J 1984;3:129-32.
57. Buzón LM, Guerrero A, Romero J, Santamaría JM. Bouza E. Penicillin-resistant Streptococcus pneumoniae meningitis successfully treated with vancomycin [letter], Eur J Clin Microbiol 1984;3:442-3.
58. Iyer PV, Kahler JH, Jacobs NM. Penicillin-resistant pneumococcal meningitis [letter]. Pediatrics 1978;61:157-8.
59. Viladrich PF, Gudiol F, Liñares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991;35:2467-72.
60. Wehrli W. Rifampin: mechanisms of action and resistance. Rev Infect Dis 1983;5(suppl 3):S407-11.
61. Odio CM, Faingezicht I, Paris M, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31.
62. Viladrich PF, Gudiol F, Liñares J, Rufi G. Ariza J, Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med 1988;84:839-46.